SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,606.00    20.00 (0.44%)
Bid:
4,604.00
Ask:
4,608.00
Spread: 4.00 (0.087%)
Market Cap: £16.79b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

CCH - Board Committees Composition

17 May 2023 15:44

RNS Number : 7744Z
Coca-Cola HBC AG
17 May 2023
 

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca-Cola HBC AG

 

 

Zug, Switzerland - 17 May 2023 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that following the election of the board members at the AGM the composition of the Board Committees will be as follows:

 

Audit and Risk Committee

William W. (Bill) Douglas (Chair) 

 

Olusola (Sola) David-Borha 

 

Alexandra Papalexopoulou

Nomination Committee

Reto Francioni (Chair)

 

Charlotte J. Boyle 

 

Anna Diamantopoulou

Remuneration Committee

Charlotte J. Boyle (Chair) 

 

Reto Francioni

 

Anna Diamantopoulou

Social Responsibility Committee 

Anastasios I. Leventis (Chair)

 

Anna Diamantopoulou

 

Evguenia (Jeny) Stoitchkova

 

This announcement is made pursuant to the Financial Conduct Authority's Listing Rule 9.6.11R and there are no other matters that require disclosure under Listing Rule 9.6.13R.

 Coca‑Cola HBC Group

Investor and Analysts:

John Dawson 

Head of Investor Relations

Tel: +44 7522 619509

 john.dawson@cchellenic.com

 

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

 

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

 

Virginia Phillips

Investor Relations Manager

 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

 

 

Media:

 

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCARMITMTIBBTJ
Date   Source Headline
27th Dec 20237:04 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20235:35 pmRNSTransaction in Own Shares
21st Dec 20232:49 pmRNSDirector/PDMR Shareholding
20th Dec 20235:20 pmRNSTransaction in Own Shares
20th Dec 20237:15 amRNSTransaction in Own Shares
19th Dec 202312:50 pmRNSPublication of a Prospectus
19th Dec 202312:22 pmRNSDirector/PDMR Shareholding
19th Dec 20237:15 amRNSTransaction in Own Shares
15th Dec 20235:50 pmRNSTransaction in Own Shares
14th Dec 20235:45 pmRNSTransaction in Own Shares
14th Dec 20237:15 amRNSTransaction in Own Shares
13th Dec 20237:15 amRNSTransaction in Own Shares
12th Dec 20237:15 amRNSTransaction in Own Shares
11th Dec 20237:15 amRNSTransaction in Own Shares
8th Dec 20237:15 amRNSTransaction in Own Shares
7th Dec 20237:15 amRNSTransaction in Own Shares
6th Dec 20237:15 amRNSTransaction in Own Shares
5th Dec 20237:15 amRNSTransaction in Own Shares
4th Dec 20237:15 amRNSTransaction in Own Shares
1st Dec 20232:48 pmRNSDirector/PDMR Shareholding
1st Dec 20239:44 amRNSIssue of equity and total voting rights
1st Dec 20237:15 amRNSTransaction in Own Shares
30th Nov 20237:15 amRNSTransaction in Own Shares
29th Nov 20237:20 amRNSTransaction in Own Shares
28th Nov 20237:15 amRNSTransaction in Own Shares
27th Nov 20237:15 amRNSTransaction in Own Shares
24th Nov 20237:15 amRNSTransaction in Own Shares
23rd Nov 20237:15 amRNSTransaction in Own Shares
22nd Nov 202312:44 pmRNSREPLACEMENT - Transaction in Own Shares
22nd Nov 20237:15 amRNSTransaction in Own Shares
20th Nov 20234:45 pmRNSCommencement of share purchase programme
20th Nov 20234:12 pmRNSDirector/PDMR Shareholding
20th Nov 20233:29 pmRNSDirector/PDMR Shareholding
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights
21st Sep 202311:01 amRNSDirector/PDMR Shareholding
19th Sep 20231:02 pmRNSDirector/PDMR Shareholding
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.